A detailed history of Swedbank Ab transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Swedbank Ab holds 1,001,932 shares of JAZZ stock, worth $123 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,001,932
Previous 1,001,932 -0.0%
Holding current value
$123 Million
Previous $107 Million 4.43%
% of portfolio
0.14%
Previous 0.14%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$103.94 - $118.98 $104 Million - $119 Million
1,001,932 New
1,001,932 $107 Million
Q4 2023

Dec 09, 2024

SELL
$114.26 - $136.0 $10.7 Million - $12.8 Million
-93,809 Reduced 8.35%
1,030,228 $127 Million
Q3 2023

Dec 09, 2024

BUY
$122.0 - $145.31 $3.97 Million - $4.73 Million
32,563 Added 2.98%
1,124,037 $145 Million
Q2 2023

Dec 09, 2024

BUY
$122.5 - $147.16 $17.3 Million - $20.8 Million
141,448 Added 14.89%
1,091,474 $135 Million
Q1 2023

Dec 09, 2024

BUY
$133.98 - $160.47 $103 Million - $123 Million
768,428 Added 423.15%
950,026 $139 Million
Q4 2022

Dec 09, 2024

BUY
$129.72 - $159.85 $334,029 - $411,613
2,575 Added 1.44%
181,598 $28.9 Million
Q3 2022

Dec 09, 2024

BUY
$126.59 - $161.18 $378,757 - $482,250
2,992 Added 1.7%
179,023 $23.9 Million
Q2 2022

Dec 09, 2024

BUY
$141.59 - $168.66 $699,171 - $832,843
4,938 Added 2.89%
176,031 $27.5 Million
Q1 2022

Dec 09, 2024

BUY
$129.64 - $160.7 $921,999 - $1.14 Million
7,112 Added 4.34%
171,093 $26.6 Million
Q4 2021

Dec 09, 2024

BUY
$119.87 - $145.67 $1 Million - $1.22 Million
8,374 Added 5.38%
163,981 $20.9 Million
Q2 2021

Dec 09, 2024

BUY
$160.2 - $186.42 $1.96 Million - $2.28 Million
12,254 Added 8.55%
155,607 $27.6 Million
Q1 2021

Dec 09, 2024

BUY
$150.19 - $173.5 $21.5 Million - $24.9 Million
143,353 New
143,353 $23.6 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.7B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Swedbank Ab Portfolio

Follow Swedbank Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.